Who Owns Adaptive Biotechnologies Stock?
NASDAQ: ADPTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 99.51%
- Institutions (% of float)
- 100.81%
- Held by insiders
- 1.29%
- Institutional holders
- 425
- Institutions 98.7%
- Insiders 1.3%
- Public and other 0.0%
Who owns Adaptive Biotechnologies stock?
Institutional investors own about 99.5% of Adaptive Biotechnologies's shares, spread across 425 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.29% of ADPT.
The largest institutional holders are Viking Global Investors, L.P. (18.79%), Blackrock Inc. (9.49%) and Vanguard Capital Management LLC (4.01%). Together, the top 10 institutions control 51.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ADPT positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ADPT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Viking Global Investors, L.P. | 29.99M | 18.79% | 0.0% |
| Blackrock Inc. | 15.14M | 9.49% | +13.8% |
| Vanguard Capital Management LLC | 6.40M | 4.01% | +5.1% |
| Wellington Management Group, LLP | 5.91M | 3.70% | +53.3% |
| Vanguard Portfolio Management LLC | 5.48M | 3.43% | +21.9% |
| Shaw D.E. & Co., Inc. | 4.63M | 2.90% | +135.3% |
| Westfield Capital Management Co LP | 4.27M | 2.67% | -21.5% |
| Geode Capital Management, LLC | 3.64M | 2.28% | +0.2% |
| State Street Corporation | 3.46M | 2.17% | +7.2% |
| Invesco Ltd. | 3.09M | 1.94% | -30.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ADPT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.83M | 3.03% |
| iShares Trust-iShares Russell 2000 ETF | 3.92M | 2.46% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.88M | 1.18% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.74M | 1.09% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.68M | 1.06% |
| ALGER FUNDS-Alger Small Cap Focus Fund | 1.49M | 0.94% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.44M | 0.90% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.42M | 0.89% |
| OBERWEIS FUNDS-Oberweis Micro-Cap Fund | 1.22M | 0.76% |
| LORD ABBETT DEVELOPING GROWTH Fd., INC.-Lord Abbett Developing Growth | 1.19M | 0.75% |
Frequently asked questions
Who is the largest shareholder of Adaptive Biotechnologies?
Viking Global Investors, L.P. is the largest institutional shareholder of ADPT, owning 18.79% of shares outstanding (29.99M shares) as of its latest 13F filing.
What percentage of Adaptive Biotechnologies is owned by institutions?
Institutions own about 99.5% of ADPT shares and 100.8% of the public float.
How much of Adaptive Biotechnologies do insiders own?
Insiders, such as officers and directors, own about 1.29% of ADPT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.